Opsonix, Inc. — Form D
Opsonix, Inc. of Wakefield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-08. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-08
- Form: D
- Accession: 0001654267-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 2
- Date of first sale: 2017-10-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-298365
Issuer
- Name: Opsonix, Inc.
- CIK: 0001654267
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 301 Edgewater Place, Suite 100, Wakefield, MA, 01880
- Phone: 617-444-8644
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Daniel J Geffken | Executive Officer | La Jolla, CA |
| Brian J Pereira | Director | Wakefield, MA |
| Anne J Sissel | Director | Wakefield, MA |
| Andrew J Stevenson | Director | Cambridge, MA |
| Daniel J G Geffken | Executive Officer | Cambridge, MA |
| Brian J G Pereira | Director | Cambridge, MA |
| Lewis J Geffen | Executive Officer | Boston, MA |
| Eric J Devroe | Director | Cambridge, MA |
| Eric J Devroe | Executive Officer | Cambridge, MA |
| Priyanka J Rohatgi | Director | Cambridge, MA |
Other filings by this issuer (2)
More